Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antiphospholipid Syndrome | 5 | 2021 | 166 | 1.790 |
Why?
|
Polypharmacy | 2 | 2021 | 307 | 1.190 |
Why?
|
Antibodies, Antiphospholipid | 3 | 2021 | 72 | 0.710 |
Why?
|
Coronary Stenosis | 1 | 2023 | 802 | 0.580 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 849 | 0.460 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1548 | 0.390 |
Why?
|
Heart Failure | 5 | 2024 | 11860 | 0.380 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2021 | 2171 | 0.340 |
Why?
|
Endoscopy | 2 | 2015 | 1856 | 0.310 |
Why?
|
Lymphocytes | 1 | 2016 | 2610 | 0.310 |
Why?
|
Mitral Valve | 1 | 2016 | 1474 | 0.290 |
Why?
|
Coronary Artery Disease | 2 | 2025 | 6566 | 0.280 |
Why?
|
Bariatric Surgery | 1 | 2015 | 1012 | 0.250 |
Why?
|
Neutrophils | 1 | 2016 | 3785 | 0.220 |
Why?
|
Intestinal Perforation | 2 | 2015 | 253 | 0.210 |
Why?
|
Databases, Factual | 1 | 2019 | 8072 | 0.210 |
Why?
|
Coronary Angiography | 2 | 2025 | 4537 | 0.200 |
Why?
|
Breast Neoplasms | 4 | 2017 | 21163 | 0.200 |
Why?
|
Thrombosis | 1 | 2016 | 2955 | 0.200 |
Why?
|
Hospitalization | 2 | 2023 | 10844 | 0.190 |
Why?
|
Anti-Obesity Agents | 1 | 2024 | 240 | 0.180 |
Why?
|
Phenotype | 1 | 2019 | 16716 | 0.180 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2021 | 147 | 0.170 |
Why?
|
Obesity | 2 | 2024 | 13082 | 0.160 |
Why?
|
Stroke | 2 | 2019 | 9742 | 0.150 |
Why?
|
Catastrophic Illness | 1 | 2017 | 60 | 0.130 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15455 | 0.130 |
Why?
|
Embolism | 1 | 2019 | 401 | 0.130 |
Why?
|
Plasma Exchange | 1 | 2017 | 160 | 0.130 |
Why?
|
Stomach Rupture | 1 | 2015 | 2 | 0.130 |
Why?
|
Polydeoxyribonucleotides | 1 | 2017 | 136 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2020 | 2295 | 0.120 |
Why?
|
Esophageal Perforation | 1 | 2015 | 65 | 0.120 |
Why?
|
Duodenum | 2 | 2015 | 495 | 0.120 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2015 | 56 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1191 | 0.120 |
Why?
|
Lymphocyte Count | 1 | 2016 | 793 | 0.110 |
Why?
|
Serologic Tests | 1 | 2016 | 383 | 0.110 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2015 | 84 | 0.110 |
Why?
|
Menarche | 1 | 2017 | 538 | 0.110 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 173 | 0.110 |
Why?
|
Overweight | 1 | 2024 | 2445 | 0.110 |
Why?
|
Internationality | 1 | 2019 | 1008 | 0.110 |
Why?
|
Hydroxychloroquine | 1 | 2017 | 426 | 0.100 |
Why?
|
Surgical Instruments | 1 | 2015 | 385 | 0.100 |
Why?
|
Coronary Vessels | 1 | 2023 | 3125 | 0.100 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 520 | 0.100 |
Why?
|
Lymphatic Metastasis | 2 | 2017 | 2924 | 0.100 |
Why?
|
Age Factors | 2 | 2020 | 18472 | 0.100 |
Why?
|
Iatrogenic Disease | 1 | 2015 | 552 | 0.100 |
Why?
|
Aged | 10 | 2025 | 171544 | 0.100 |
Why?
|
Humans | 25 | 2025 | 768298 | 0.090 |
Why?
|
Anticoagulants | 4 | 2022 | 4842 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1673 | 0.090 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5168 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6319 | 0.090 |
Why?
|
Patient Care Team | 2 | 2023 | 2529 | 0.090 |
Why?
|
Echocardiography, Transesophageal | 1 | 2016 | 1095 | 0.080 |
Why?
|
Sirolimus | 1 | 2017 | 1542 | 0.080 |
Why?
|
Neutropenia | 1 | 2015 | 893 | 0.080 |
Why?
|
Cardiology | 1 | 2020 | 1701 | 0.080 |
Why?
|
Risk Factors | 5 | 2025 | 74954 | 0.080 |
Why?
|
Brain | 1 | 2016 | 27452 | 0.080 |
Why?
|
Female | 16 | 2025 | 397050 | 0.080 |
Why?
|
Menopause | 1 | 2017 | 1653 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1881 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2023 | 59683 | 0.080 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4874 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1378 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 13050 | 0.070 |
Why?
|
Adult | 8 | 2024 | 223622 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10588 | 0.060 |
Why?
|
Middle Aged | 9 | 2025 | 223463 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3859 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2763 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4209 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10117 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8501 | 0.050 |
Why?
|
Echocardiography | 1 | 2016 | 5044 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8378 | 0.050 |
Why?
|
Risk Assessment | 2 | 2022 | 24316 | 0.050 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2021 | 32 | 0.050 |
Why?
|
Warfarin | 2 | 2020 | 1493 | 0.050 |
Why?
|
Male | 8 | 2025 | 364870 | 0.040 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2025 | 407 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10863 | 0.040 |
Why?
|
Pregnancy | 1 | 2019 | 30198 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 329 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2017 | 235 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54921 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2025 | 81768 | 0.030 |
Why?
|
American Heart Association | 1 | 2020 | 1051 | 0.030 |
Why?
|
United States | 2 | 2020 | 73144 | 0.030 |
Why?
|
Acute Disease | 2 | 2016 | 7242 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40267 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 525 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2024 | 2240 | 0.030 |
Why?
|
Ferritins | 1 | 2017 | 601 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 41791 | 0.030 |
Why?
|
Boston | 1 | 2024 | 9371 | 0.020 |
Why?
|
Rectum | 1 | 2015 | 900 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3942 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4043 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5620 | 0.020 |
Why?
|
Genomics | 1 | 2025 | 5916 | 0.020 |
Why?
|
Emergencies | 1 | 2015 | 1219 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2518 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36849 | 0.020 |
Why?
|
Syndrome | 1 | 2015 | 3275 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3905 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2016 | 2247 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15868 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7453 | 0.020 |
Why?
|
Colon | 1 | 2015 | 1805 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2491 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4921 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2948 | 0.020 |
Why?
|
Prognosis | 2 | 2017 | 30020 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 65365 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2588 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3471 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6808 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9635 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26373 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21544 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11254 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20766 | 0.010 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_